751 related articles for article (PubMed ID: 16758944)
1. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
2. The effect of acute normovolemic hemodilution and acute hypervolemic hemodilution on coagulation and allogeneic transfusion.
Saricaoglu F; Akinci SB; Celiker V; Aypar U
Saudi Med J; 2005 May; 26(5):792-8. PubMed ID: 15951872
[TBL] [Abstract][Full Text] [Related]
3. [Hypervolemic hemodilution as a means of preventing homologous blood transfusion. A simple alternative to acute normovolemic hemodilution].
Entholzner E; Mielke L; Plötz W; Malek A; Kling M; Burgkart R; Hargasser S; Hipp R
Fortschr Med; 1994 Oct; 112(29):410-4. PubMed ID: 7528160
[TBL] [Abstract][Full Text] [Related]
4. [A comparison of autologous transfusion procedures in hip surgery].
Lorentz A; Osswald PM; Schilling M; Jani L
Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822
[TBL] [Abstract][Full Text] [Related]
5. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery.
Habler O; Schwenzer K; Zimmer K; Prager M; König U; Oppenrieder K; Pape A; Steinkraus E; Reither A; Buchrot A; Zwissler B
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):467-75. PubMed ID: 15183411
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
Penner M; Fingerhut D; Tacke A
Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
[TBL] [Abstract][Full Text] [Related]
7. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
9. [Isovolemic hemodilution for avoiding homologous blood transfusions: effectiveness in large gynecologic interventions].
Oberhauser M; Bardenheuer HJ; Bernasconi H; Genz T; Kreimeier U
Infusionsther Transfusionsmed; 1996 Feb; 23(1):15-23. PubMed ID: 8653011
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions].
Vogt N; Bothner U; Georgieff M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 May; 29(3):150-6. PubMed ID: 7519062
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.
Jarnagin WR; Gonen M; Maithel SK; Fong Y; D'Angelica MI; Dematteo RP; Grant F; Wuest D; Kundu K; Blumgart LH; Fischer M
Ann Surg; 2008 Sep; 248(3):360-9. PubMed ID: 18791356
[TBL] [Abstract][Full Text] [Related]
13. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery.
Chakravarthy M; Muniraj G; Patil S; Suryaprakash S; Mitra S; Shivalingappa B
Ann Card Anaesth; 2012; 15(2):105-10. PubMed ID: 22508200
[TBL] [Abstract][Full Text] [Related]
14. Preoperative acute hypervolemic hemodilution with hydroxyethylstarch: an alternative to acute normovolemic hemodilution?
Mielke LL; Entholzner EK; Kling M; Breinbauer BE; Burgkart R; Hargasser SR; Hipp RF
Anesth Analg; 1997 Jan; 84(1):26-30. PubMed ID: 8988994
[TBL] [Abstract][Full Text] [Related]
15. Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery.
Virmani S; Tempe DK; Pandey BC; Cheema AS; Datt V; Garg M; Banerjee A; Wadhera A
Ann Card Anaesth; 2010; 13(1):34-8. PubMed ID: 20075533
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
[TBL] [Abstract][Full Text] [Related]
17. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.
Kozek-Langenecker SA; Jungheinrich C; Sauermann W; Van der Linden P
Anesth Analg; 2008 Aug; 107(2):382-90. PubMed ID: 18633012
[TBL] [Abstract][Full Text] [Related]
18. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients.
Van der Linden PJ; De Hert SG; Daper A; Trenchant A; Schmartz D; Defrance P; Kimbimbi P
Can J Anaesth; 2004 Mar; 51(3):236-41. PubMed ID: 15010405
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
